Polymorphisms in codon 31 of p21 and cervical cancer susceptibility in Korean women.

The aim of this study was to determine whether the codon 31 genotype of p21 might be associated with an increased risk of cervical cancer development in Korean women. We used tissue derived from patients with invasive cervical cancer (ICC) (n=111, composed of two histologic groups: squamous cell carcinoma (n=67) and adenocarcinoma (n=44)), cervical intraepithelial neoplasia (CIN) III (n=101), and non-cancer controls (NCC, n=98). For the determination of p21 polymorphism, genomic DNA was examined by polymerase chain reaction-restriction fragment length polymorphism assay using BsmAI. We compared the distribution of the p21 genotype in ICC, CIN III, and control and also analyzed the association of this polymorphism with the risk of development of cervical cancer, especially in patients with high-risk human papillomavirus (HPV) (16 or 18)-positive cervical cancer. A significant increase of Ser/Ser genotype frequency was found in adenocarcinoma patients with high-risk HPV (16 or 18) compared with the NCC group (P=0.009). The odds ratio was 3.59 (95% CI 1.55-8.31) when comparing adenocarcinoma patients associated with high-risk HPV with NCC. We found that the codon 31 Ser/Ser homozygote of the p21 gene could be a risk factor for the development of cervical adenocarcinoma associated with high-risk HPV.

[1]  K. Fukuchi,et al.  Molecular analysis of the Cip1/Waf1 (p21) gene in diverse types of human tumors. , 1995, Biochimica et biophysica acta.

[2]  K. Kato,et al.  WAF1 genotype and endometrial cancer susceptibility. , 1999, Gynecologic oncology.

[3]  Julian Peto,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[4]  P. Silcocks,et al.  Squamous and adenocarcinoma of the uterine cervix: a comparison using routine data. , 1987, British Journal of Cancer.

[5]  S. Groshen,et al.  WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. , 1997, The American journal of pathology.

[6]  R. Birgander,et al.  Association between the p21 codon 31 A1 (arg) allele and lung cancer. , 1996, Human heredity.

[7]  G. Morley,et al.  A comparison of adenocarcinoma and squamous cell carcinoma of the cervix , 1991, Obstetrics and gynecology.

[8]  D. Maintz,et al.  Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours. , 1995, British Journal of Cancer.

[9]  D. Givol,et al.  A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. , 1994, Oncogene.

[10]  R. Hayes,et al.  No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  D. Grignon,et al.  Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer. , 1995, Oncogene.

[12]  M. Becich,et al.  Association between human cancer and two polymorphisms occurring together in the p21Waf1/Cip1 cyclin‐dependent kinase inhibitor gene , 1997, Cancer.

[13]  T. Eide.  Cancer of the uterine cervix in Norway by histologic type, 1970-84. , 1987, Journal of the National Cancer Institute.

[14]  P. D. Lee,et al.  Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer. , 1995, Human molecular genetics.

[15]  R. Birgander,et al.  The codon 31 polymorphism of the p53-inducible gene p21 shows distinct differences between major ethnic groups. , 1996, Human heredity.